Skip to main content
Skip to main content
AHG logo

Akso Health Group (AHG)

$1.51 $-0.01 (-0.66%) |CouncilHOLD · 54 · B
Signals are mixed — the Council read leans HOLD (54/100) while the AI fundamental score is 67/100 (grade B+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Ray Dalio bullish.
MCap: $143.04M| Vol: 8.9K| 52-wk range: $0.83 – $2.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Akso Health Group (AHG) trades at $1.51 with AI Score 67/100 (Grade B+). Akso Health Group (AHG) is a social e-commerce platform based in China, offering a diverse range of products through its Xiaobai Maimai App. Market cap: $143.04M, Sector: Financial services.

Price live · AI analysis from Jun 14, 2026
Akso Health Group (AHG) is a social e-commerce platform based in China, offering a diverse range of products through its Xiaobai Maimai App. Founded in 2014, the company has evolved to provide consultancy and IT support services while operating as a subsidiary of Webao Limited.

Analyst Coverage for AHG: AHG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AHG against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 54/100 · B

AHG: 4/5 perspectives are bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Izzy Englander
Bullish
Seth Klarman
Bullish
Moon AI
Neutral
Council Score · 8 perspectives · See tabs for details →

Akso Health Group (AHG) Financial Services Profile

CEOYilin Wang
Employees9
HeadquartersQingdao, CN
IPO Year2017

Akso Health Group operates a social e-commerce platform in China, providing a wide array of products and services through its Xiaobai Maimai App, positioning itself within the growing digital commerce landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for AHG?

Akso Health Group's investment thesis is anchored in its unique position within the rapidly expanding social e-commerce sector in China. With a market capitalization of $143.04M, the company is poised to benefit from the increasing consumer shift towards online shopping, particularly in the post-pandemic environment. The Xiaobai Maimai App serves as a critical growth driver, offering a diverse product range that appeals to a broad consumer base. Despite its current challenges reflected in a profit margin of -1713.4% and a gross margin of -6.0%, the company's strategic focus on consultancy and IT services provides additional revenue opportunities. Furthermore, as the e-commerce market in China continues to grow, projected to reach $2 trillion by 2025, Akso Health Group's innovative platform and product offerings could position it favorably for future profitability and market share expansion.

Based on FMP financials and quantitative analysis

AHG Key Highlights

  • Market capitalization of $143.04M, indicating a small but potentially growing market presence.
  • Profit margin of -1713.4%, highlighting current financial challenges but also potential for turnaround.
  • Gross margin of -6.0%, reflecting the company's ongoing efforts to improve operational efficiency.
  • Beta of -0.66, suggesting lower volatility compared to the market, which may appeal to risk-averse investors.
  • No dividend yield, indicating reinvestment of earnings into growth initiatives.

Who Are AHG's Competitors?

AHG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
JD JD.com, Inc. $26.73 +0.39% $36.09B 44
BABA Alibaba Group Holding Limited $97.84 +1.77% $234.78B 54
PDD PDD Holdings Inc. $83.74 +1.64% $119.20B 58
ATLC Atlanticus Holdings Corporation $96.44 +0.04% $1.46B 71
LPRO Open Lending Corporation $3.13 +0.64% $370.35M 68
ATLCZ Atlanticus Holdings Corporation 9.25% Senior Notes due 2029 $25.30 +0.38% $1.46B 68
ATLCL Atlanticus Holdings Corporation 6.125% Senior Notes due 2026 $25.26 +0.04% $1.46B 66
MCVT Mill City Ventures III, Ltd. $6.11 -4.98% $501.70M 66

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AHG's Key Strengths?

  • Diverse product offerings catering to various consumer needs.
  • Strong presence in the growing social e-commerce market.
  • Innovative app platform enhancing user engagement.

What Are AHG's Weaknesses?

  • Negative profit and gross margins indicating financial challenges.
  • Limited workforce of nine employees may hinder scalability.
  • Dependency on the Chinese market exposes it to regional risks.

What Could Drive AHG Stock Higher?

  • Expansion of product offerings on the Xiaobai Maimai App to include more health-related products.
  • Continuous improvement of the app's user interface to enhance customer engagement and retention.
  • Strategic partnerships with local brands to increase product visibility and drive sales.

What Are the Key Risks for AHG?

  • Negative return on equity (-67.6%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Regulatory changes in China's e-commerce sector that could impact operational practices.
  • Intense competition from established players like Alibaba and JD.com, which could affect market share.
  • Economic fluctuations in China that may influence consumer spending patterns.

What Are the Growth Opportunities for AHG?

  • Growth opportunity 1: The Chinese e-commerce market is projected to grow significantly, reaching approximately $2 trillion by 2025. Akso Health Group can capitalize on this growth by expanding its product offerings and enhancing its app functionalities to attract more users. The increasing trend of online shopping presents an opportunity for Akso to capture a larger market share in the social e-commerce space.
  • Growth opportunity 2: Akso Health Group's consultancy and IT support services can be further developed to cater to other businesses in the e-commerce sector. As digital transformation accelerates, the demand for IT solutions and consultancy is expected to rise, providing Akso with a potential revenue stream that complements its core e-commerce operations.
  • Growth opportunity 3: The focus on health-related products aligns with global consumer trends towards wellness and self-care. By expanding its range of health and wellness products on the Xiaobai Maimai App, Akso Health Group can tap into the growing health-conscious consumer base, which is projected to continue increasing in the coming years.
  • Growth opportunity 4: Partnerships with local brands and influencers can enhance product visibility and drive sales on the Xiaobai Maimai App. Collaborating with established names in the food, beverage, and fashion industries can attract new customers and increase engagement, ultimately boosting revenue.
  • Growth opportunity 5: The rise of mobile payment solutions in China provides an opportunity for Akso Health Group to integrate seamless payment options within its app. By enhancing the user experience through convenient payment methods, the company can improve conversion rates and customer satisfaction.

What Opportunities Does AHG Have?

  • Expanding the range of health and wellness products.
  • Leveraging digital transformation trends in the consultancy sector.
  • Potential partnerships with influencers and local brands.

What Threats Does AHG Face?

  • Intense competition from established e-commerce giants.
  • Regulatory challenges in the Chinese e-commerce landscape.
  • Market volatility affecting consumer spending behaviors.

What Are AHG's Competitive Advantages?

  • Unique social e-commerce platform that integrates various product categories.
  • Strong brand recognition through the Xiaobai Maimai App.
  • Established relationships with suppliers and brand partners.
  • Ability to leverage parent company Webao Limited's resources and expertise.
  • Focus on customer engagement through social commerce strategies.

What Does AHG Do?

Founded in 2014, Akso Health Group, originally known as Xiaobai Maimai Inc., has established itself as a significant player in the social e-commerce sector in China. The company is headquartered in Beijing and operates the Xiaobai Maimai App, which serves as a comprehensive mobile platform offering an extensive range of products including food and beverages, cosmetics, fashion, entertainment, and home appliances. In December 2021, the company rebranded to Akso Health Group, reflecting its broader focus on health-related products and services. As a subsidiary of Webao Limited since July 2021, Akso Health Group leverages its parent company's resources to enhance its market presence and operational capabilities. The company also provides consultancy and information technology support services, further diversifying its revenue streams. With a small workforce of nine employees, Akso Health Group aims to capitalize on the growing trend of social commerce, which is increasingly popular among consumers seeking convenience and variety in their shopping experiences. The company’s innovative approach to product promotion and its commitment to customer engagement through its app position it well within the competitive landscape of e-commerce in China.

What Products and Services Does AHG Offer?

  • Operates the Xiaobai Maimai App, a social e-commerce mobile platform.
  • Offers a wide range of products including food, beverages, cosmetics, and home appliances.
  • Provides consultancy and information technology support services.
  • Trades in branded products and promotes various consumer goods.
  • Engages in social commerce to enhance customer interaction and sales.
  • Operates as a subsidiary of Webao Limited, leveraging additional resources.

How Does AHG Make Money?

  • Generates revenue through product sales on the Xiaobai Maimai App.
  • Offers consultancy services to other businesses in the e-commerce sector.
  • Provides IT support services, creating additional income streams.
  • Engages in promotional activities for branded products to drive sales.
  • Utilizes social commerce strategies to enhance customer engagement and loyalty.

What Industry Does AHG Operate In?

The social e-commerce industry in China is experiencing rapid growth, driven by increasing smartphone penetration and changing consumer behaviors. As more consumers turn to online platforms for shopping, the market is projected to reach approximately $2 trillion by 2025. Akso Health Group operates within this dynamic landscape, competing against established players and emerging startups. The competitive landscape includes various companies that offer similar platforms, but Akso's focus on a wide range of products and services through its Xiaobai Maimai App provides a unique positioning. Additionally, the integration of social elements into e-commerce is a key trend that Akso is leveraging to enhance customer engagement and drive sales.

Who Are AHG's Key Customers?

  • Consumers seeking a diverse range of products through a single mobile platform.
  • Health-conscious individuals looking for wellness-related products.
  • Businesses in need of consultancy and IT support services.
  • Brand partners interested in promoting their products through the Xiaobai Maimai App.
  • Young, tech-savvy consumers who prefer online shopping.
AI Confidence: 65% Updated: Jun 14, 2026

FY2026 estForward Outlook

Wall Street analysts project Akso Health Group revenue of about $108.3M for fiscal 2026, with EPS near $4.02.

F-Score 2/9Financial Health

Akso Health Group's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 5.01 places it in the safe zone, indicating low near-term bankruptcy risk.

ROE -68%Key Financial Metrics

Return on equity for Akso Health Group stands at -67.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -63.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 4.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.53 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -26.6%, the inverse of the P/E and a quick read on earnings relative to price.

Akso Health Group (AHG) Valuation Context

Valued at $143.04M, AHG is classified as a micro-cap stock. Relative to its peer group, AHG's quantitative score of 67/100 is roughly in line with the peer average of 59/100.

AHG Revenue & Earnings Trend

In Q1 2025, AHG generated $3.9M in top-line revenue, marking a sequential increase of 0.0%. The company recorded a net loss of $67.2M, with diluted EPS of $-0.20. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Financial Services. Across the four most recent quarters, AHG averaged $-0.10 in diluted EPS.

Company Profile

Akso Health Group operates in the Financial - Credit Services industry within the Financial Services sector. It is headquartered in Qingdao, CN. The company is led by CEO Yilin Wang. AHG has traded publicly since 2017.

AHG Financials

Fundamental Snapshot

EPS Growth (FY)
-6.7%
Free Cash Flow Growth (FY)
-24.3%
Return on Equity (TTM)
-67.6%
Current Ratio
1.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Akso Health's future, indicating that executives believe in the company's growth potential.
  • Community sentiment has shifted positively, with discussions highlighting Akso's innovative healthcare solutions gaining traction.
  • The healthcare sector is experiencing increased demand, and Akso's focus on health technology positions it well to capitalize on this trend.
  • Recent partnerships announced by Akso have generated excitement, signaling potential for expanded market reach and revenue growth.

Bear Case

  • Despite recent positive sentiment, some analysts remain cautious about Akso's ability to scale its operations effectively in a competitive market.
  • Concerns over regulatory challenges in the healthcare sector could impact Akso's growth trajectory and market entry strategies.
  • There is a notable bearish sentiment among some community members regarding Akso's financial sustainability amid rising operational costs.
  • Market perception remains mixed, with some investors questioning the long-term viability of Akso's business model in a rapidly evolving industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2025 $4M -$67M -$0.20
Q4 2024 $4M -$67M -$0.20
Q3 2024 $3M -$293,316 -$0.0039
Q2 2024 $3M -$293,316 -$0.0039

Based on FMP financials and quantitative analysis

AHG Latest News

AHG Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AHG.

Price Targets

Wall Street price target analysis for AHG.

AHG MoonshotScore

67/100

What does this score mean?

The MoonshotScore rates AHG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Yilin Wang

CEO

Yilin Wang has been at the helm of Akso Health Group since its inception in 2014. With a strong background in business management and technology, he has played a pivotal role in the company's evolution from Xiaobai Maimai Inc. to Akso Health Group. Wang's leadership has been instrumental in navigating the complexities of the e-commerce sector in China, focusing on innovation and customer engagement.

Track Record: Under Yilin Wang's leadership, Akso Health Group has successfully rebranded and expanded its product offerings. His strategic vision has led to the development of the Xiaobai Maimai App, enhancing the company's position in the competitive social e-commerce landscape.

Akso Health Group ADR Information Sponsored

An American Depositary Receipt (ADR) is a negotiable certificate representing shares in a foreign company, allowing U.S. investors to buy shares in non-U.S. companies. Akso Health Group operates as a Level II ADR, which means its shares are traded on U.S. exchanges and provide investors with a way to invest in the company's equity without dealing with foreign stock exchanges directly.

  • Home Market Ticker: Qingdao, CN
  • ADR Level: 2
  • ADR Ratio: 1:1
Currency Risk: ADR holders are exposed to currency risk as the underlying shares are denominated in Chinese Yuan (CNY). Fluctuations in the exchange rate between the CNY and the U.S. dollar can affect the value of the ADRs, impacting returns for U.S. investors.
Tax Implications: U.S. investors in Akso Health Group's ADRs may be subject to foreign dividend withholding tax rates, which can vary based on tax treaties between the U.S. and China. Investors should consult tax professionals to understand the implications of investing in foreign securities.
Trading Hours: The trading hours for Akso Health Group's shares in China differ from U.S. trading hours. The Chinese stock market typically operates from 9:30 AM to 3:00 PM local time, while U.S. markets operate from 9:30 AM to 4:00 PM EST. This time difference can impact trading strategies for U.S. investors.

Common Questions About AHG (Financial Services)

What does Akso Health Group do?

Akso Health Group operates a social e-commerce mobile platform in China, primarily through its Xiaobai Maimai App. The platform offers a diverse range of products, including food, beverages, cosmetics, and home appliances. Additionally, the company provides consultancy and IT support services, enhancing its operational capabilities and revenue streams.

What are the main risks for AHG?

Akso Health Group faces several risks, including intense competition from established e-commerce giants like Alibaba and JD.com, which could limit market share growth. Regulatory challenges in the Chinese e-commerce landscape may also pose risks to operational practices. Additionally, economic fluctuations in China could impact consumer spending behaviors, affecting sales and profitability.

What are the key factors to evaluate for AHG?

Akso Health Group (AHG) holds an AI score of 67/100 (moderate). Not financial advice.

How frequently does AHG data refresh on this page?

AHG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven AHG's recent stock price performance?

Akso Health Group (AHG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product offerings catering to various consumer needs. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AHG overvalued or undervalued right now?

Valuing Akso Health Group (AHG) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying AHG?

Before investing in Akso Health Group (AHG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding AHG to a portfolio?

Key strength of Akso Health Group (AHG): Diverse product offerings catering to various consumer needs. Its MoonshotScore of 67/100 reflects solid quantitative fundamentals. Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on available information as of June 2026. Financial metrics are subject to change based on market conditions.
Data Sources

Popular Stocks